SBIR-STTR Award

Artificial Salivary Gland Dental Implant
Award last edited on: 3/25/2019

Sponsored Program
STTR
Awarding Agency
NIH : NIDCR
Total Award Amount
$223,315
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
John Robert Kelly

Company Information

Oral Fluid Dynamics LLC

400 Farmington Avenue R1844
Farmington, CT 06032

Research Institution

----------

Phase I

Contract Number: ----------
Start Date: ----    Completed: ----
Phase I year
2018
Phase I Amount
$223,315
Xerostomia, or dry mouth, affects approximately 20% of the U.S. population, some 64 million people by causing oral discomfort and pain due to chronically dry mucosa. This condition leads to oral disease such as caries and candidiasis, and has no cure or adequate treatment. Many remedial approaches have been tried with only limited success, including the provision of fluid to the mouth via frequent sipping, various mouthwashes, sprays and lozenges, electric stimulation of native salivary glands (ineffective for Sjögren’s patients), and potential cellular regeneration strategies to augment or replace salivary glands. Oral Fluid Dynamics, LLC (OFD) proposes to treat Xerostomia with a radically new approach: A dental implant to harvest and filter fluid from the jaw bone and to discharge the filtered fluid into the mouth as substitute saliva. OFD’s pilot animal studies have demonstrated that dental implants can harvest fluid within mandibular bone over a two-year period, that the fluid is abundantly available and constantly replenished, and that it could provide a continual supply of oral fluid for the relief of Xerostomia. Dental implants are currently the standard of care to replace missing teeth and have shown to be successful for patients of all ages with few limitations regarding systemic health. Many Xerostomic patients are middle and older age and are often missing teeth, affording the opportunity to address both problems with this specially designed implant. The overall goal of this project is to develop a dental implant device that serves as a salivary gland replacement that will change the standard of care for patients with Xerostomia.

Public Health Relevance Statement:
Relevance to Public Health: Dry mouth (xerostomia) due to abnormally low salivation affects 64 million people in the United States, resulting directly from immunological compromise of salivary glands (Sjögren’s Syndrome) as well as from side-effects of medications and post- radiation treatment of head/neck cancer. Dry mouth causes discomfort, pain, tooth decay, and fungal infection. Oral Fluid Dynamics, LLC is developing a standard dental implant device that moves continuously available fluid residing inside jaw bones through a membrane filter and into the mouth as a saliva substitute.

Project Terms:
Address; Adverse effects; Affect; Age; Anatomy; Animal Testing; Animals; Area; Biomedical Engineering; bone; Bone Marrow; Candidiasis; Chronic; commercial application; Dental; Dental caries; Dental Implants; design; Development; Device Designs; Devices; Electric Stimulation; Eye; Filtration; Funding; Future; Goals; Harvest; Head and Neck Cancer; Health; Immunologics; Implant; implant design; implantable device; In Situ; innovation; Jaw; Light; Liquid substance; Mandible; Manufacturer Name; Market Research; Marrow; Mastication; materials science; Maxilla; Membrane; Miniaturization; miniaturize; Molecular Weight; Motion; Mouth Diseases; Mouthwash; Mucous Membrane; Mycoses; Natural regeneration; novel strategies; Operative Surgical Procedures; Oral; Oral cavity; Osmosis; Pain; Patient Care; Patients; Performance; Pharmaceutical Preparations; Phase; phase 1 testing; Population; pressure; Prosthodontic specialty; prototype; Public Health; Pump; Radiation therapy; Research Personnel; Saline; Saliva; saliva secretion; Salivary Glands; self-renewal; Sjogren's Syndrome; Sodium Chloride; standard of care; success; surgery material; System; Technology; Testing; Tooth structure; United States; Work; Xerostomia

Phase II

Contract Number: ----------
Start Date: ----    Completed: ----
Phase II year
----
Phase II Amount
----